Daiichi Sankyo (Switzerland)

Daiichi Sankyo is dedicated to the creation and supply of innovative pharmaceutical products to address the diversified, unmet medical needs of patients in both mature and emerging markets. While maintaining its portfolio of marketed pharmaceuticals for hypertension, hyperlipidemia and bacterial infections, Daiichi Sankyo is also engaged in the development of treatments for thrombotic disorders and focuses on the discovery of novel oncology and cardiovascular-metabolic therapies. The companys roots extend back to 1899 and the early days of industrialisation of the pharmaceutical sector. The company was created in 2005 through the merger of two traditional Japanese enterprises, Daiichi and Sankyo. Daiichi...

Cardiovaskuläre produkte and onkologieprodukte

Daiichi sankyo (switzerland) operates in the Pharmaceutical manufacturing industry.

Daiichi sankyo (switzerland)'s revenue is 11m - 100m

Daiichi sankyo (switzerland) has 51 - 200 employees.